• 2008

Company Description

Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.

Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.